These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 10392035
1. [Hypophyseal thyrotropin adenomas at Yaounde (Cameroon). Analysis of two case reports: improvement with somatostatin analogue (SMS 201-995)]. Nouedoui C, Moukouri E, Juimo AG, Dongmo L, Zok FD, Tapko JB, Muna WF. Tunis Med; 1999 Mar; 77(3):154-8. PubMed ID: 10392035 [No Abstract] [Full Text] [Related]
2. TSH-secreting pituitary macroadenoma: rapid tumor shrinkage and recovery from hyperthyroidism with octreotide. Fischler MP, Reinhart WH. J Endocrinol Invest; 1999 Jan; 22(1):64-5. PubMed ID: 10090139 [Abstract] [Full Text] [Related]
4. [Monosymptomatic hyperthyroidism and TSH-producing adenoma: successful therapy with octreotide]. Mayinger B, Axelos D, Pavel M, Hahn EG, Hensen J. Dtsch Med Wochenschr; 1999 Jan 29; 124(4):73-8. PubMed ID: 10071603 [Abstract] [Full Text] [Related]
5. [Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide]. Laczi F, Magony S, Julesz J. Orv Hetil; 2002 May 12; 143(19 Suppl):1062-6. PubMed ID: 12063861 [Abstract] [Full Text] [Related]
6. [Thyroid-stimulating hormone hypophyseal adenoma. A case report]. Gannage MH, Maacaron C, Okais N, Halaby G. J Med Liban; 1997 May 12; 45(2):97-101. PubMed ID: 9289506 [Abstract] [Full Text] [Related]
7. [Response of thyrotropinoma to somatostatin analogues: report of a case]. García Lafuente N, Berná Gascón MT, Pujalte López E, Falcó Jover G, Domínguez Escribano JR. An Med Interna; 2001 Dec 12; 18(12):663. PubMed ID: 11852512 [No Abstract] [Full Text] [Related]
8. Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. Comi RJ, Gesundheit N, Murray L, Gorden P, Weintraub BD. N Engl J Med; 1987 Jul 02; 317(1):12-7. PubMed ID: 2884564 [Abstract] [Full Text] [Related]
9. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature. Yoenem A, Cakyr B, Azal O, Corakcy A, Kutlu M, Oezata M. Endocr Regul; 1999 Dec 02; 33(4):169-74. PubMed ID: 10700085 [Abstract] [Full Text] [Related]
10. TSH secreting pituitary adenoma: a rare cause of thyrotoxicosis. So WY, Yeung VT, Chow CC, Ko GT, Szeto CC, Cockram CS. Int J Clin Pract; 1998 Dec 02; 52(1):62-4. PubMed ID: 9536575 [Abstract] [Full Text] [Related]
11. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment. Teramoto A, Sanno N, Tahara S, Osamura YR. Acta Neuropathol; 2004 Aug 02; 108(2):147-53. PubMed ID: 15185102 [Abstract] [Full Text] [Related]
12. Proliferation activity in somatotroph pituitary adenomas. Delgrange E, Donckier J. Mayo Clin Proc; 1998 Oct 02; 73(10):1027-8. PubMed ID: 9787756 [No Abstract] [Full Text] [Related]
13. [The role of somatostatin analogues in the treatment of hypophyseal adenomas]. Losa M, Mortini P, Giovanelli M. Minerva Endocrinol; 2003 Mar 02; 28(1):39-51. PubMed ID: 12621362 [Abstract] [Full Text] [Related]
14. [New elements in the diagnosis and treatment of thyrotropic pituitary adenomas with hyperthyroidism]. Linquette M, Cappoen JP, Mazzuca M. Bull Acad Natl Med; 1989 Feb 02; 173(2):217-20; discussion 221-2. PubMed ID: 2765997 [Abstract] [Full Text] [Related]